Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biocon Ltd. Regulatory Filings 2020

Oct 28, 2020

61176_rns_2020-10-28_20cdb449-b18b-40de-8fb4-17200c338d83.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [119 x 47] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN : L24234KA1978PLC003417

www.biocon.com

Date of submission: October 28, 2020

To To The Secretary The Secretary BSE Limited National Stock Exchange of India Limited Department of Corporate Services Corporate Communication Department Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai – 400 001 Mumbai – 400 050 Scrip Code - 532523 Scrip Symbol- BIOCON

Dear Sir/Madam,

Sub: Meeting conducted with Institutional Investors/Research Analysts.

Ref: Intimation under Regulation 30 (6) of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.

Pursuant to Regulation 30 (6) of the SEBI LODR Regulations, 2015, we hereby inform you that the following meeting was conducted with Institutional Investor / Research Analysts:

Date
Name
Type of meeting Location
October 28,2020 HSBC Global Asset Management(UK)Ltd. Teleconference Bangalore

We request you to kindly take above intimation on record.

Thanking You,

Yours faithfully,

For Biocon Limited

==> picture [78 x 29] intentionally omitted <==


==> picture [77 x 81] intentionally omitted <==

Mayank Verma Company Secretary and Compliance Officer